NLRP3-IN-79
NLRP3-IN-79 is an orally active NLRP3 inhibitor. NLRP3-IN-79 inhibits NLRP3 inflammasome with an IC50 of 10.69 nM. NLRP3-IN-79 blocks NLRP3 inflammasome assembly by directly binding to NLRP3 and disrupting the NEK7-NLRP3 interaction. NLRP3-IN-79 can be used for the study of NLRP3-driven diseases model, including systemic inflammation, peritonitis, and colitis[1].
Product Specifications
CAS Number
3088796-72-6
UNSPSC
12352005
Target
Interleukin Related; NEKs; NOD-like Receptor (NLR)
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Smiles
CCNC(N(CC1=CN=CC=C1)CC(NC2=C3C(CCC3)=CC4=C2CCC4)=O)=O
Molecular Formula
C23H28N4O2
Molecular Weight
392.49
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-1; IL-18; NEK7; NLRP3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse IgG2b Antibody ATTO 550 Conjugated Pre-adsorbed
